Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mydecine Innovations Group Inc. Proxy Solicitation & Information Statement 2025

Jan 21, 2025

47221_rns_2025-01-21_138db203-1b81-4859-9d6c-f261695cd375.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

NATIONAL SECURITIES ADMINISTRATORS LTD.
702 – 777 Hornby Street
Vancouver, BC, V6Z 1S4
[email protected]
www.transferagent.ca

Mydecine Innovations Group Inc.

Via SEDAR+

January 21, 2025

TO ALL APPLICABLE REGULATORS AND EXCHANGES

RE: Mydecine Innovations Group Inc.
Notice of Meeting and Record Dates
(the "Issuer")

We advise the following with respect to the Issuer's upcoming Meeting of Security Holders:

1 Meeting Type Special Meeting
2 Record Date for Notice of Meeting January 27, 2025
3 Record Date for Voting (If Applicable) January 27, 2025
4 Beneficial Ownership Determination Date January 27, 2025
5 Meeting Date March 13, 2025
6 Meeting Location TBA
7 Voting Securities Details
8 Description (Class) Common
9 ISIN / CUSIP CA62849F2008 / 62849F200
10 Issuer sending proxy related materials directly to Non-Objecting Beneficial Owners (NOBOs) No
11 Issuer paying for mailing to Objecting Beneficial Owners (OBOs) No
12 Notice and Access
Beneficial Holders Yes
Registered Holders Yes
Stratification Level Not Applicable
13 Material Selection S - All & Special Materials

Regards,

National Securities Administrators Ltd.

Agent for Mydecine Innovations Group Inc.